Page last updated: 2024-10-29

irsogladine and Mucositis

irsogladine has been researched along with Mucositis in 1 studies

irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt

Mucositis: An INFLAMMATION of the MUCOSA with burning or tingling sensation. It is characterized by atrophy of the squamous EPITHELIUM, vascular damage, inflammatory infiltration, and ulceration. It usually occurs at the mucous lining of the MOUTH, the GASTROINTESTINAL TRACT or the airway due to chemical irritations, CHEMOTHERAPY, or radiation therapy (RADIOTHERAPY).

Research Excerpts

ExcerptRelevanceReference
"Alimentary mucositis is a significant complication of cancer therapy, with important clinical and economic implications."2.43Anti-inflammatory agents in the management of alimentary mucositis. ( Bensadoun, RJ; Keefe, D; Lalla, RV; Schubert, MM, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lalla, RV1
Schubert, MM1
Bensadoun, RJ1
Keefe, D1

Reviews

1 review available for irsogladine and Mucositis

ArticleYear
Anti-inflammatory agents in the management of alimentary mucositis.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2006, Volume: 14, Issue:6

    Topics: Allopurinol; Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antineoplastic Agents; Benzydamin

2006